Mitochondrial Genome Sequencing

CPT: 81460

Expected Turnaround Time

2 - 4 weeks

Specimen Requirements


Whole blood, oral swab, or extracted DNA


4 mL, 1 swab, or 200 ng of DNA

Minimum Volume

1 mL, 1 swab, or 100 ng of DNA


Whole blood: lavender-top (EDTA) tube; oral swab: OCD-100 DNA Genotek device only; extracted DNA: sterile screw capped vial


Draw blood into EDTA tube.

Storage Instructions

Blood: Ship ASAP, but stable up to 5 days post-collection at room temperature. Do not freeze. Swab: 60 day post-collection room temperature stability; DNA: Ship at room temperature after extraction.

Stability Requirements

• Room temperature: 5 days

• Refrigerated: 5 days

• Frozen: Do not freeze

Causes for Rejection

Frozen blood EDTA tube; insufficient swab cell collection; frozen blood EDTA tube; insufficient swab cell collection ratio outside of 1.8-2.0 range

Test Details


This test is used to diagnose mitochondrial disease that is caused by point mutations or small deletions/duplications in the mtDNA. MtDNA point mutations are the most important class of variants detected by this test. While some mitochondrial disorders caused by mtDNA point mutations only affect a single organ (e.g. the eye in Leber hereditary optic neuropathy [LHON]), many involve multiple organ systems and often present with prominent neurologic and myopathic features. Mitochondrial disorders may present at any age. Many individuals with a mutation of mtDNA display a cluster of clinical features that fall into a discrete clinical syndrome, such as the Kearns-Sayre syndrome (KSS), chronic progressive external ophthalmoplegia (CPEO), mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS), myoclonic epilepsy with ragged-red fibers (MERRF), neurogenic weakness with ataxia and retinitis pigmentosa (NARP), or Leigh syndrome (LS). However, considerable clinical variability exists, and many individuals do not fit neatly into one particular category, which is well-illustrated by the overlapping spectrum of disease phenotypes.


This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.


Next-Generation Sequencing

For Providers

Please login to order a test

Order a Test

© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at Additional information regarding LOINC® codes can be found at, including the LOINC Manual, which can be downloaded at